FDA Authorizes Pfizer's COVID-19 Vaccine for Children 5 to 11
The dosage is at one-third of the vaccine dose used for people 12 and older
Today, the U.S. Food and Drug Administration (FDA) issued emergency use authorization for Pfizer's COVID-19 vaccine for children 5 to 11. This is the first COVID-19 vaccine authorized in the United States for younger children.
On Tuesday, the FDA's vaccine advisers voted 17-0, with one abstention, to recommend EUA for the vaccine, which is formulated at one-third the dose of the vaccine used for people 12 and older.
Pfizer says a clinical trial showed its vaccine provides greater than 90 percent protection against symptomatic disease among children, even at one-third the dose, and the company hopes the lower dose will reduce the risk of any side effects.
Please select this link to read the complete article from CNN.